The frequency of both IL-17-producing CD4+ and CD8+ cells is significantly increased in AD patients compared to healthy controls (92), and the frequency of Th17 cells is most elevated in the prodromal phase of AD, where their ratio negatively correlates with the CSF Aβ42/Aβ40 ratio (87, 93). Here, CD8A is linked to Alzheimer disease.